High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After Vaccination-Reference-Cited by-同舟云学术

High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After Vaccination

Published:2015-05-07 Issue:5 Volume:10 Page:e0125618
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kaur Kaval,Zheng Nai-Ying,Smith Kenneth,Huang Min,Li Lie,Pauli Noel T.,Henry Dunand Carole J.,Lee Jane-Hwei,Morrissey Michael,Wu Yixuan,Joachims Michelle L.,Munroe Melissa E.,Lau Denise,Qu Xinyan,Krammer Florian,Wrammert Jens,Palese Peter,Ahmed Rafi,James Judith A.,Wilson Patrick C.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference66 articles.

1. Predominant autoantibody production by early human B cell precursors;H Wardemann;Science,2003

2. Defective B cell tolerance checkpoints in systemic lupus erythematosus;S Yurasov;J Exp Med,2005

3. Persistent expression of autoantibodies in SLE patients in remission;S Yurasov;J Exp Med,2006

4. Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity;Z Sabouri;Proceedings of the National Academy of Sciences of the United States of America,2014

5. Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors;B Mietzner;Proc Natl Acad Sci U S A,2008

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B cells in the balance: Offsetting self-reactivity avoidance with protection against foreign;Frontiers in Immunology;2022-07-25

2. Silencing and activating anergic B cells*;Immunological Reviews;2021-12-14

3. Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses;Immunity;2020-12

4. Machine Learning to Quantify In Situ Humoral Selection in Human Lupus Tubulointerstitial Inflammation;Frontiers in Immunology;2020-11-27

5. Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment;Rheumatology;2020-10-02